- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Undervalued Dividend Payers
Hong Kong Pharmaceuticals & Biotech Undervalued Dividend Payers
Results
5
Companies available at a discount paying at least a 2% dividend yield.
5 companies
CSPC Pharmaceutical Group
Market Cap: HK$101.6b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$8.89
7D
3.7%
1Y
95.0%
China Medical System Holdings
Market Cap: HK$32.8b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.57
7D
4.3%
1Y
91.4%
China Resources Pharmaceutical Group
Market Cap: HK$28.6b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.56
7D
0.7%
1Y
-16.5%
Grand Pharmaceutical Group
Market Cap: HK$28.0b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$7.99
7D
1.5%
1Y
75.6%
SSY Group
Market Cap: HK$8.5b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.92
7D
1.4%
1Y
-14.4%